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ABSTRACT - With the aim of analyzing which complementary tests are relevant in the diagnostic evaluation of
individuals with pervasive developmental disorders, a protocol of clinical and laboratory evaluation was applied
in 103 outpatients. The protocol included chromosomal analysis, screening for inborn errors of metabolism,
cytogenetic and molecular study of the FRAXA, FRAXE, and FRAXF mutations, EEG, SPECT, and magnetic
resonance imaging study. Eighty-four subjects concluded the complementary tests and were classified either
as having autism, atypical autism or Asperger syndrome according to the DSM-IV criteria. Sixteen individuals,
all bellonging to the two autistic groups, presented genetic or enviromental factors that may have lead to the
behavioral disorders, showing the importance of diagnostic evaluation in this group of conditions. Neuroimaging
and EEG findings were non-specific and occurred in similar proportion among the groups, being considered
of relative low significance in the diagnostic evaluation of individuals with pervasive developmental disorders.
KEY WORDS: autism, Asperger syndrome, pervasive developmental disorders, fragile X syndrome, SPECT,
magnetic resonance imaging.
Avaliação genética e neurológica em uma amostra de indivíduos com transtornos globais do
desenvolvimento
RESUMO - Visando analisar quais exames complementares são relevantes na avaliação diagnóstica de uma
amostra de indivíduos com transtornos globais do desenvolvimento, 103 pacientes atendidos em nível
ambulatorial foram submetidos a um protocolo composto por avaliação clínica e exames complementares, os
quais incluíam cariótipo, estudo molecular da síndrome do cromossomo X frágil, cromatografia de aminoácidos,
EEG, SPECT e ressonância magnética. Foram selecionados 84 indivíduos que completaram a investigação
laboratorial e apresentavam diagnóstico de autismo, autismo atípico ou síndrome de Asperger, de acordo
com os critérios do DSM-IV. Em 16 indivíduos foram identificados distúrbios ambientais ou geneticamente
determinados que podem ter causado o quadro comportamental, ressaltando a importância de uma avaliação
diagnóstica meticulosa em tais casos. Os achados de neuroimagem e EEG foram inespecíficos e estiveram
presentes em proporções semelhantes entre os três grupos, sendo considerados pouco elucidativos na avaliação
diagnóstica de indivíduos com transtornos globais do desenvolvimento.
PALAVRAS-CHAVE: autismo, síndrome de Asperger, transtornos globais do desenvolvimento, síndrome do
cromossomo X frágil, SPECT, ressonância magnética.
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Pervasive developmental disorders (PDDs) are a
heterogeneous group of neurobehavioral disorders
of childhood, comprising autism (the most common
form of PDD), atypical autism, Asperger syndrome,
Rett syndrome, and PDD not otherwise specified. All
these entities are clinically characterized by abnor-
malities in three main areas: social interaction, lan-
guage and communication, and interests and activi-
ties1. The clinical picture is quite variable among af-
fected individuals2. Up to 75% present mental retar-
dation, and epilepsy is manifested in more than 30%,
suggesting the occurence of extensive brain damages
by the action of neurobiological factors3, 4. Initially
thought to have psychogenic origin, PDDs are now
considered neuropsychiatrical conditions determined
by still less understood factors acting in a multifac-
torial model. The more recent advances in this field
have been generated by neuroanatomical and neuro-
physiological researchs on the central nervous sys-
tem, as well as molecular studies with the aim of
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determining gene(s) involved in their etiology. In at
least 10% of the cases a specific etiology can be iden-
tified such as environmental factors, chromosomal
abnormalities or single gene disorders4-6, with special
attention to the association of fragile X syndrome
and autism.
In the absence of specific laboratory findings, se-
veral diagnostic scales and manuals were created on
the basis of the clinical aspects, in order to define
the diagnosis of PDDs. The most useful are the criteria
listed in the Diagnostic and Statistical Manual of
Mental Disorders (DSM) from the American Psychia-
tric Association1. Considering the heterogeneity of
the PDDs and the high prevalence of associated con-
ditions, individuals with a preliminary diagnosis of
autism or related disorders should be evaluated in a
systematic and interdisciplinary way, including a de-
tailed clinical evaluation and complementary tests.
The aim of this study was to identify and analyse
genetic and neurological aspects in a sample of in-
dividuals presenting PDDs by using a protocol of clini-
cal and laboratory assessment7,8 and define which
ones are relevant in the diagnostic evaluation of the-
se conditions.
METHOD
A total of 103 individuals from the ambulatories of
Genetics and Neurology were referred with a preliminary
diagnosis of autism. Parents or legal guardians were invited
to join the study by signing an informed consent term
approved by our institutional Ethics Committee.
A comprehensive protocol comprising clinical interview,
physical and neurologic examination with attention to dys-
morphologic evaluation was applied. Functional diagnosis
was based on the DSM-IV criteria for the PDDs1. Etiological
diagnosis comprised cytogenetic analysis including tech-
niques for fragile X chromosome9. Molecular studies of
the FRAXA mutation using the PCR technique10 and the
Southern blotting technique11 were also performed, as well
as analysis for the FRAXE and FRAXF mutations following
proper protocols12,13. Other complementary tests were
screening for inborn errors of metabolism and aminoacid
chromatography on urine and plasma samples14.
Neurological assesment included EEG, SPECT, and mag-
netic resonance imaging. EEG followed the international
10-20 system15 in a 16 channel Berger (BergerÒ, Brazil)
equipment. SPECT images were acquired under general
anaesthesia in a gamma-chamber capting endovenous
Tc99m-HMPAO contrast16. Magnetic resonance imaging
(MRI) was also obtained under general anaesthesia in a
2.0 Tesla Elscint PrestigeÒ (Haifa, Israel) equipment17.
The chi-square test of significance was used to give a
measure of the significance (p < 0.05) of an observed
deviation from the expected value. Comparasion was made
among the groups in the sample and with a control group
that included individuals presenting mental retardation
without Down syndrome18, besides data from the
literature.
RESULTS
The 103 outpatients initially evaluated comprised
84 males and 19 females (sex ratio 4.4:1) with ages
ranging from 2.6 to 28.6 years (mean 9.9 years).
Functional diagnosis based on DSM-IV criteria revea-
led that 68 individuals presented autism while 16
had atypical autism and 11 received the diagnosis
of Asperger syndrome. Eight patients were excluded
due to other neurobehavior diagnosis than autism:
2 manifested Rett syndrome, 3 actually had infantile
psychosis, and 3 presented mental retardation but
no autism. Besides these eight patients and despite
the diagnosis of one of the PDDs, other 11 subjects
did not conclude their clinical and laboratory
evaluation and were also excluded. The remaining
84 individuals that composed the final sample were
classified in three groups: autism, atypical autism,
and Asperger syndrome. Characteristics of each
group are shown on Table 1.
Following the protocol, a detailed clinical history
revealed that 3 individuals presented significant
environmental factors that may have contributed to
the autistic features: one girl had sequelae from pre-
Table 1. Characteristics of each group that composed the final sample.
Autism Atypical Asperger Total
 autism syndrome
n 60 13 11 84
Sex ratio (M:F) 54:6 (9:1) 9:4 (2,2:1) 8:3 (2,7:1) 71:17 (4,1:1)
Mean patients age (years) 10 7.4 11.8 9.9
Mean maternal age (years) 27.7 23.7 28.1 27.1
Mean paternal age (years) 29.5 26.9 29.5 29.3
M, male; F, female.
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maturity associated to severe neonatal hypoxia, other
girl had a post-vaccinal (MMR) encephalitis at age 9
months, and a boy had neonatal meningitis . Clinical
evaluation identified three patients with Down syn-
drome, as well as six individuals with other dysmor-
phic genetic conditions.
Concerning the complementary tests, structural
chromosomal abnormalities were found in three indi-
viduals besides the three patients with Down syndro-
me. Other cytogenetic finding was the presence of
the fragile site at Xq27.3 in four patients, three of
them showing a very low positivity rate (1 to 4%) and
another with a consistent positivity (17%). Molecular
analysis revealed that the later individual had a mosaic
expansion of CGG from 100 to 900 repetitions in the
FMR1 gene while the other three patients were
negative for the FRAXA, FRAXE, and FRAXF mutations.
In two subjects the biochemical tests detected the
presence of hyperphenylalaninemia and phenylke-
tonuria leading to the diagnosis of untreated
phenylketonuria.
Details of the clinical and complementary tests
are shown on Table 2.
Due to technical problems, some individuals did not
conclude the neurological complementary evaluation.
A total of 70 EEGs were performed with 49 (71%)
normal results and 21 (29%) abnormal results. The
autistic group presented two cases of generalized
epileptiform activity, three of unspecified generalized
desorganization, and two of unspecified hemispheric
desorganization (one in the right and the other in
the left hemisphere). Unspecified focal desorgani-
zation was detected in six individuals presenting au-
tism, four presenting atypical autism, and five with
Asperger syndrome.
Fifty-eight subjects underwent SPECT imaging re-
sulting in 26 (45%) normal, one (2%) inconclusive,
and 31 (53%) abnormal results with similar propor-
tion among the groups. Nine individuals with autism
and one with Asperger syndrome presented hypo-
perfusion of the frontal lobes, while 10 with autism,
two with atypical autism and one with Asperger syn-
drome showed hypoperfusion of the cerebelum. Hy-
poperfusion of the basal ganglia was seen in two
patients with autism, one with atypical autism, and
one with Asperger syndrome. Abnormal unilateral
or bilateral temporal lobe perfusion occured in nine
subjects with autism, six with atypical autism, and
four with Asperger syndrome. One individual with
Asperger syndrome had abnormal occipital lobe per-
Table 2. Conditions diagnosed after clinical evaluation and complementary tests.
Condition Etiology N Functional Comments
diagnosis
Chromosomal abnormalities:
Down syndrome 47,XY,+21 3 autism
pericentric inversion or chrom. 9 46,XY,inv(9) 1 atypical maternally inherited
(p13;q13) autism
robertsonian translocation 15/21 45,XY,rob(15;21) 1 atypical maternally inherited
(p10;p10) autism
polymorphic Y 46,XYqh+ 1 autism no further investigation
Monogenic disorders:
untreated PKU AR 2 autism consanguineous parents, IVS10nt-11g/a
tuberous sclerosis AD 1 autism normal parents
fragile X syndrome XLR 1 autism fra(X) 17%; 100-900 CGG repeats
FG syndrome XLR 1 autism MR, hypotonia, obstipation
acrocallosal syndrome AR 1 autism MR, polydactyly, abnormal CNS
MR, macrocephaly, dysmorphisms AR 1 autism affected brother and twin sister
MR, autism, dysmorphism AR? 1 autism consanguineous parents
Non-genetic conditions:
neonatal meningites 1 autism
prematurity, neonatal encephalopathy 1 atypical
autism
post-vaccinal encephalatis 1 atypical
autism MMR vaccine
AD, autosomal dominant; AR, autosomal recessive; CNS, central nervous system; fra(X), fragile site at Xq27.3; MMR, mumps, measles, rubella; MR, mental
retardation; XLR, X-linked recessive; ?, unknown/uncertain.
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fusion. Abnormal left hemisphere perfusion, abnor-
mal cingulate girus, and the inconclusive test were
found in one individual each of the autistic group.
Finally, 63 patients concluded the neuroanato-
mical evaluation which revealed 44 (70%) normal
exams and 19 (30%) abnormal results, two of them
showing specific abnormalites related to the syndro-
mic diagnosis (acrocallosal syndrome and tuberous
sclerosis, one case each), and the remaining revealing
variable findings. Thinning or partial agenesis of the
corpus callosum was seen in two individuals with
autism. Hypoplasia of the cerebelar vermis was pre-
sent in one subject with autism and other with aty-
pical autism. One individual with atypical autism sho-
wed ectopic cerebelar tonsilae and reduction of the
superior right temporal lobe with enlarged silvyan
fissure. Perivascular enlargment was detected in one
individual with autism and in other with Asperger
syndrome. Gliosis was found in three individuals, one
of each group. Non-hypertensive enlargment or assi-
metry of the lateral ventricules was seen in four pa-
tients with autism, two with atypical autism, and
one with Asperger syndrome.
DISCUSSION
Several conditions with genetic etiologies have
been described in association with autism19. Some
deserve mention due to a consistent association, such
as tuberous sclerosis or fragile X syndrome, and just
a few seem to be strictly associated with autistic fea-
tures, like the entity described by Orstavick et al.20
as a dysmorphic condition comprising macrocephaly,
epilepsy, mental retardation, and autism. However,
most of these descriptions represent anecdotal re-
ports indicating a probable casual relationship, like
the association of acrocallosal syndrome with autism
which is, to our knowledge, the first report in the
literature. Cytogenetic analysis showed that three
individuals with Down syndrome had trisomy21. Au-
tism is frequently seen in persons with Down syn-
drome in spite of a pleasant and sociable personality
usually described in this condition21. Other 3 subjects
presented structural abnormalities including one case
each of Yqh+, pericentric inversion of chromosome
9, and Robertsonian translocation 15/21, the two
latter being maternally inherited. Previously descri-
bed in autism22, Yqh+ is considered a polymorphism
without clinical significance and does not justify the
neurological picture seen in this patient. On the other
hand, pericentric inversion of chromosome 9 is
common in the general population and usually cau-
ses no abnormal phenotype, although recent data
suggest that it may be involved in genetic suscep-
tibility to psychiatric disorders such as schizophrenia
or even autism23. The roberstonian translocation 15/
21 deserves mention because abnormalities of chro-
mosome 15 have a higher prevalence in autism than
in the general population24 and frequently have ma-
ternal origin25.
Abnormalities in the FMR1 gene cause the fragile
X syndrome, an X-linked condition with a wide range
of deviant behaviours, from mental impairment in
variables degrees to hyperactivity and autistic featu-
res. Studies in the 80s suggested that fragile X syn-
drome was present in a great number of autistic sub-
jects, and it was even proposed that it would be the
cause of autism. However, recent data showed that it
can be identified in less than 3% of autistic individuals,
a value similar to its prevalence in samples based in
other developmental disorders like mental retardation,
learning disabilities or speech delay26.
Phenylketonuria is a well known autosomal reces-
sive condition that has also been described in asso-
ciation with autism4, although its frequency is de-
creasing in industrialised countries after the intro-
duction of neonatal screening and early dietary treat-
ment. Molecular analysis showed that both patients
present the same mutation (IVS10nt-11g/a) in the
phenylalanine hydroxilase gene, a genotype that
leads to severe biochemical defect and consequent
worse clinical picture27.
Concerning the neurological tests, abnormalities
in the EEG were found in 30% of the total sample,
similar to previous reports in the literature28. A slight
predominance of electroencephalografic abnorma-
lities in the temporal regions was detected but sta-
tistical analysis revealed no difference in relation to
other cerebral regions or among the three groups.
Neuroimaging (MRI) abnormalities occurred in
30% of the three groups, but no specific structural
abnormality was found. Cerebellar hypoplasia has
been described as a possible neuroimaging marker
for autism29, however in the present sample it occur-
red in equal proportions among the autistic and the
Asperger groups, and was present either in idiopathic
autism as in autism due to a specific condition. Sta-
tistical analysis revelead a higher incidence of abnor-
malities in the group formed by autistic individuals
with a specific syndromic diagnosis (P2(4) = 15.67; p
= 0.003), which is probably correlated with the
associated diagnosis but not with autism itself.
Although SPECT abnormalities were detected in
more than 50% of the individuals in the present sam-
ple, showing the higher sensibility among the three
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tests, it revealed no specificity in autism30. In spite
of cerebellum and frontal lobe(s) seemed to be more
affected, no statistical difference was observed in
relation to the other areas.
Finally, there was no correlation in anatomical
areas or clinical severity when results from the three
neurological tests were compared.
CONCLUSION
The association of autism with an environmental
or genetic condition must be considered in any indi-
vidual presenting abnormalities in the socialization,
communication, and/or activities, despite the level
of intellectual functioning. Clinical evaluation of such
cases should comprise, besides careful information
about behavior patterns, a dysmorphologic exami-
nation to search for suggestive signs of neurogenetic
disorders. Concerning the laboratory tests, karyotype
and molecular tests for the fragile X syndrome should
be included in the investigation of autism. If mole-
cular tests are not available, cytogenetic analysis in
folic acid deficient medium is an alternative. On the
other hand, EEG or neuroimaging exams may bring
few benefits for the patient or his family and should
be performed depending of individual indication, but
not as a routine. We believe that the identification
of typical and pure cases of autism will be usefull
for neuroimaging researchs involving new techno-
logies that may be available in a near future.
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